Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Inflammation in people with HIV is associated with cardiovascular disease and other serious health conditions.
Cure rates are high, but some young people already have advanced liver damage by the time they’re treated.
HIV-positive people with a higher viral load over a longer period appear more likely to develop hepatocellular carcinoma.
This is according to the large randomized controlled START trial.
In an analysis of the liver health of a cohort of HIV/hep B–coinfected people, one third had significant fibrosis.
Those with greater fibrosis before treating hep C see the greatest benefit.
Researchers believe this genetic mutation protected against the 14th century-bubonic plague.
AZT and ddI were the main drugs associated with liver damage in a new study.
Multiple studies have reached this conclusion, raising concerns about sexually transmitted hep C among gay and bi men who have HIV.
A long-term study of women living with both viruses found a link between accelerated fibrosis progression and perimenopause.
A look at a large cohort of Canadians with HIV and hepatitis C also examined modifiable factors associated with a reduced risk of death.
Regardless of whether individuals have hepatitis B or C, the improvement tends to occur quickly.
A high HIV viral load and a low CD4 count are each independently linked to liver fibrosis progression among those with and without hep C.
For people coinfected with HIV and hepatitis C virus (HCV), waiting to start HCV treatment until they progress through the levels of liver fib...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.